These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 20739347)

  • 1. Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.
    Schott JM; Frost C; MacManus DG; Ibrahim F; Waldman AD; Fox NC
    Brain; 2010 Nov; 133(11):3315-22. PubMed ID: 20739347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ; Pina MA; Fayed N; Díaz M
    CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic changes in the anterior and posterior cingulate cortices of the normal aging brain: proton magnetic resonance spectroscopy study at 3 T.
    Chiu PW; Mak HK; Yau KK; Chan Q; Chang RC; Chu LW
    Age (Dordr); 2014 Feb; 36(1):251-64. PubMed ID: 23709317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
    J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome.
    Montal V; Barroeta I; Bejanin A; Pegueroles J; Carmona-Iragui M; Altuna M; Benejam B; Videla L; Fernández S; Padilla C; Aranha MR; Iulita MF; Vidal-Piñeiro D; Alcolea D; Blesa R; Lleó A; Fortea J;
    Ann Neurol; 2021 Sep; 90(3):407-416. PubMed ID: 34309066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M; Moriya M; Nojo T
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease.
    Dixon RM; Bradley KM; Budge MM; Styles P; Smith AD
    Brain; 2002 Oct; 125(Pt 10):2332-41. PubMed ID: 12244089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents.
    Davanzo P; Yue K; Thomas MA; Belin T; Mintz J; Venkatraman TN; Santoro E; Barnett S; McCracken J
    Am J Psychiatry; 2003 Aug; 160(8):1442-52. PubMed ID: 12900307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
    Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
    Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.
    Antuono PG; Jones JL; Wang Y; Li SJ
    Neurology; 2001 Mar; 56(6):737-42. PubMed ID: 11274307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy in the evaluation of children with congenital heart disease and acute central nervous system injury.
    Ashwal S; Holshouser BA; Hinshaw DB; Schell RM; Bailey L
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):403-14. PubMed ID: 8751509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease.
    Lowe AJ; Rodrigues FB; Arridge M; De Vita E; Johnson EB; Scahill RI; Byrne LM; Tortelli R; Heslegrave A; Zetterberg H; Wild EJ
    Brain Commun; 2022; 4(6):fcac258. PubMed ID: 36382217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.
    Forester BP; Finn CT; Berlow YA; Wardrop M; Renshaw PF; Moore CM
    Bipolar Disord; 2008 Sep; 10(6):691-700. PubMed ID: 18837863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.
    Gomar JJ; Gordon ML; Dickinson D; Kingsley PB; Uluğ AM; Keehlisen L; Huet S; Buthorn JJ; Koppel J; Christen E; Conejero-Goldberg C; Davies P; Goldberg TE
    Biol Psychiatry; 2014 May; 75(9):686-92. PubMed ID: 23831342
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Joe E; Medina LD; Ringman JM; O'Neill J
    Brain Imaging Behav; 2019 Aug; 13(4):925-932. PubMed ID: 29907927
    [No Abstract]   [Full Text] [Related]  

  • 20. N-acetyl-aspartate, total creatine, and myo-inositol in the epileptogenic human hippocampus.
    Petroff OA; Errante LD; Kim JH; Spencer DD
    Neurology; 2003 May; 60(10):1646-51. PubMed ID: 12771256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.